Festoons swelling on cheekbone under eye describes soft, puffy, horizontal bands of tissue that appear beneath the eyes and extend from the cheekbone toward the lower eyelid. These are not bags of fat but rather a combination of displaced fat, loose skin, and underlying structural changes. They typically develop gradually with age and become more visible during periods of fatigue, dehydration, or salt intake.
This condition results from the natural descent of facial fat pads and weakening of connective tissues. The malar (cheek) fat pad shifts downward and forward, creating a bulge along the lower eyelid and upper cheek. This movement is exacerbated by gravity, sun damage, and repetitive facial expressions. Unlike eyelid bags, which are localized and often linked to genetics or allergies, festoons span a wider area and do not resolve with cold compresses or sleep.
A 2021 study in the journal Plastic and Reconstructive Surgery found that 68% of patients aged 45 and older show some degree of festoon formation, especially those with fair skin and thin dermis. The condition is more common in individuals who have undergone multiple dermal filler treatments, particularly around the midface, because improper placement can push fat downward and distort tissue planes.
Festoons form due to a combination of anatomical changes. The orbicularis oculi muscle, which surrounds the eye, becomes less effective at supporting the skin and subcutaneous layers. As collagen and elastin degrade with age, the skin loses elasticity. Fat that normally rests in the deeper layers of the face migrates into the lower eyelid region, creating a soft, doughy appearance.
Unlike acute swelling from infection or allergy, festoons are chronic and persistent. They do not fluctuate daily like fluid retention-related puffiness. Instead, they remain stable unless influenced by lifestyle factors such as high sodium intake, alcohol consumption, or lack of sleep. Even after adequate rest, the puffiness remains visible.
One key distinction: festoons are not edema. Edema involves fluid accumulation in tissues, causing temporary swelling that may reduce with elevation or diuretics. Festoons involve structural tissue displacement, making them resistant to such interventions. A 2019 clinical review in Journal of Cosmetic Dermatology confirmed that 92% of festoon cases showed no improvement with antihistamines or corticosteroids, reinforcing their non-inflammatory nature.
Festoons are classified based on severity and anatomical origin:
| Type | Description | Common Triggers |
|---|---|---|
| Primary festoons | Present from early adulthood, often genetic. Associated with prominent malar fat pads. | Family history, early-onset facial fat redistribution |
| Secondary festoons | Develop later in life due to aging, UV exposure, or filler misuse. | Age 40+, cumulative sun damage, overfilling with hyaluronic acid |
| Post-surgical festoons | Result from invasive procedures like blepharoplasty or midface lifts. | Incorrect surgical technique, scar contracture |
Secondary festoons are most common in clinical practice. A 2022 retrospective analysis of 347 cosmetic patients found that 31% developed festoon-like changes within 6 months of receiving dermal fillers in the malar or tear trough areas. Overfilling in the lateral midface was the strongest predictor, with a 4.3-fold increased risk compared to conservative injection techniques.
One non-obvious factor: facial asymmetry. Many patients report that festoons appear more pronounced on one side. This occurs because the facial skeleton is rarely perfectly symmetrical. The left orbit often sits slightly lower than the right, leading to uneven fat distribution and greater prominence on the dominant side.
Festoons most frequently appear between ages 35 and 60. They are more noticeable in people with lighter skin tones due to reduced pigmentation masking the underlying tissue. Individuals with a history of seasonal allergies or chronic sinus issues may misattribute festoon appearance to inflammation, but the persistence beyond symptom resolution indicates a structural cause.
They are commonly mistaken for allergic reactions, conjunctivitis, or even early signs of thyroid disease. However, unlike these conditions, festoons do not cause itching, redness, or vision changes. They are purely cosmetic and do not affect ocular function.
I observed this firsthand while reviewing patient photos during a dermatology rotation. A 52-year-old woman presented with bilateral lower eyelid puffiness. She had no history of allergies or recent illness. After ruling out infection and autoimmune markers, we diagnosed secondary festoons. Her symptoms persisted despite antihistamines and nasal steroids. Only after referral to a facial plastic surgeon did she receive treatment focused on tissue repositioning, not symptom suppression.
Festoons swelling on cheekbone under eye is often confused with:
The key differentiator is consistency. Festoons remain unchanged through sleep cycles and do not improve with hydration or rest. True edema resolves within hours. If swelling persists for days without other symptoms, structural causes like festoons should be considered.
Another common error: assuming all lower eyelid puffiness is treatable with fillers. Injecting volume into the tear trough can temporarily mask festoons, but it often worsens the appearance by adding bulk to an already overstretched area. A 2020 study in Aesthetic Surgery Journal reported that 41% of patients treated with fillers for "bags" ended up with more pronounced festoons due to overcorrection.
Non-surgical options are limited. Topical retinoids may improve skin texture over time but do not correct tissue displacement. Laser resurfacing can tighten skin slightly but fails to address the root issue. Oral diuretics provide no lasting benefit.
Surgical correction involves repositioning or removing excess fat and tightening the lower eyelid support structures. Techniques include transconjunctival blepharoplasty with fat repositioning or midface suspension using sutures or mesh. Recovery takes 10-14 days, with final results visible after 6 weeks.